10:27 AM EDT, 04/04/2025 (MT Newswires) -- Biotech company Telo Genomics ( TDSGF ) is a rare gainer across Canadian stock markets on Friday, edging up from near 52 week lows, after announcing that John Farlinger has joined its board of directors, and will chair the company's audit committee.

Farlinger is a veteran venture and private equity-backed executive and entrepreneur, bringing more than 30 years of experience in telecom, operations, technology and finance. He currently serves as Assure Neuromonitoring's executive chairman and chief executive officer.

The company's shares were last seen up $0.01, to $0.11, on the TSX Venture Exchange.

Price: 0.11, Change: +0.01, Percent Change: +10.00